Crossmark

Value of ultrafast and standard dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the presence and extension of residual disease after neoadjuvant chemotherapy in breast cancer

Crossref DOI link: https://doi.org/10.1007/s11604-021-01110-y

Published Online: 2021-03-20

Published Print: 2021-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kato, Erina

Mori, Naoko https://orcid.org/0000-0002-8700-9731
Mugikura, Shunji

Sato, Satoko

Ishida, Takanori

Takase, Kei
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (18K07742, 19K17159)
License Information

Text and Data Mining valid from 2021-03-20

Version of Record valid from 2021-03-20
More Information

Article History

Received: 14 December 2020

Accepted: 13 March 2021

First Online: 20 March 2021

Declarations

:

: Erina Kato has nothing to disclose. Naoko Mori has nothing to disclose. Shunji Mugikura has nothing to disclose. Satoko Sato has nothing to disclose. Takanori Ishida has nothing to disclose. Kei Takase has nothing to disclose.

: Our Institutional Review Board approved this retrospective study and waived the informed consent requirement.

Document is current

Any future updates will be listed below